Immunohistochemistry (IHC) and Immunofluorescence (IF) are powerful techniques for detecting tissue-based biomarkers enhancing traditional histological analysis. These methods enable cellular-level assessments of protein expression and spatial organization within a single tissue section, providing critical insights into their roles in therapeutical outcomes. By facilitating high-resolution biomarker analysis, IHC and IF support precision medicine in translational research and clinical practice.
By leveraging cutting-edge multiplex staining, high-sensitivity imaging platforms, and AI-powered analysis, our approach ensures greater precision, higher throughput, and enhanced reproducibility compared to traditional single-marker assays. These technologies enable comprehensive spatial mapping of biomarkers, delivering more meaningful data for drug development, translational research, and precision medicine applications.
